Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. . Lancet 2022;400:359-368.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. Lancet 2022;400:359-368.
PMID: 35908569